Promea promises a wide range of support.
Promea Therapeutics is an innovative medical device
manufacturing company specializing in Life Sciences, Diagnostics
which includes Clinical Chemistry, Immunodiagnostics, Molecular Diagnostics and Infusion Therapies.
We believe that "A picture is worth a thousand words & a video is worth a million emotions". We are presenting handpicked collection of various snaps and video clips connected with Promeans & Promea's products.
We firmly believe that the technology should support people and people should focus on what matters. Embarking our
journey, we have successfully adopted & developed many unique products embedded with diverse technologies.
We're also pleased to have earned different ISO certifications for internal quality standards and good manufacturing practices, as well as recognitions for our focus on producing products that encourage our manufacturing capability & environmental sustainability.
We believe that the people behind a company are as important as the company itself. You're likely to find that kind of personalities who have brought the wealth of skills and experience from a wide range of backgrounds.
Promea's Electrolyte is world's most Innovative and affordable solution for mid size laboratories.
Promea catering the needs of efficient labs with world's most efficient Hematology Analyzers.
Promea's Semi Automated Biochemistry Analyzer is one of the maintenance free semi auto analyzer.
Promea is delivering Point Of Care Immuno Assay products
embedded with advanced technologies.
Promea has developed & commercialized the affordable
& connected glucose meter solutions.
Promea dedicates the development of Hemoglobin Meter to Anemia Mukt Bharat
Promea covers wide range of infectious rapids as well as specialty parameters of rapids.
Promea bringing the affordable automation to
compliment the productivity of Elisa Kits.
Promea has developed diverse range of RT-PCR
solutions to cater the testing needs
Promea's unique range of Biologics produces various parameters of injectables.
Promea is developing user friendly products prioritizing the Home Health Care.
Promea has indigenously developed lot of ancillary products to cater various diagnostic testing needs.
Promea manufactures a wide range of High Quality Fluid Therapy Products.
At Promea we're building a global team of amazing people. If you're curious, ambitions and ready to grow your career with us, we'd love to meet you !
We introduce the activities of the R&D Center, the
core of PROMEA.
With 1 person dying every 30 seconds due to hepatitis related illness, the importance of controlling and curbing the spread of this deadly disease has never been as important since its onset in the 17th century.
The 5 mainly identified types of hepatitis are: A, B, C, D, and E, although we are currently experiencing and unexplained a new outbreak of acute hepatitis infections affecting children. The new outbreak that does not belong to any of the 5 above mentioned categories are currently being extensively studied in the respective regions of outbreak. Although many of these infections show only mild symptoms and go undetected but, in some cases, can prove fatal. The death toll due to hepatitis A through E globally surpassed 75,000 per annum for the past 3 years. Global estimates say that only 16% of the worlds hepatitis B infection has been diagnosed and 25 % for hepatitis C and less than 10 % are receiving adequate treatment.
Along with the global efforts along to curb the spread of acute hepatitis infections the priority is also taken to completely eradicate B, C and D Infections which causes chronic hepatitis, lasting over decades which reflect in over 1 million deaths due to liver cirrhosis and liver cancer.
People centric alignment of systems and integration is crucial to reach a goal of at least 60 % of total diagnosis of hepatitis infection and 50 % treatment of hepatitis related infections by 2025.
We the general public can help with this mission by keeping in mind a few simple precautions:
ProTip: Recognizing the year’s theme of bringing hepatitis care closer to you, the first step and most crucial step is to get tested. Promea’s ELISA and rapid based hepatitis testing kits have been validated and confirmed by leading plasma collection facilities and are fully equipped to provide the quality and speed of testing required to achieve WHO’s goal of diagnosis of infections by 2025.
#Worldhepatitisday #liverfunction #WHO #Promea #Medicaldevices #YourHealthOurpromise